Primary prophylaxis with tacrolimus in kidney transplants in China.
Cheng
H M
HM
Division of Nephrology, Queen Elizabeth Hospital, Hong Kong, China.
Wong
F K
FK
Choi
K S
KS
Cheng
Y L
YL
Chak
W L
WL
Chan
Y H
YH
Chau
K F
KF
Li
C S
CS
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002681:China; D003586:Cytomegalovirus Infections / Q000150:complications; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D000961:Antilymphocyte Serum; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents; D001379:Azathioprine; D016559:Tacrolimus